Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis

被引:24
作者
de Rijke, Eva [1 ]
Essers, Martien L. [1 ]
Rijk, Jeroen C. W. [1 ]
Thevis, Mario [2 ]
Bovee, Toine F. H. [1 ]
van Ginkel, Leendert A. [1 ]
Sterk, Saskia S. [1 ]
机构
[1] RIKILT Inst Food Safety, European Union Reference Lab, Wageningen, Netherlands
[2] German Sport Univ Cologne, Ctr Prevent Doping Res, Inst Biochem, Cologne, Germany
来源
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT | 2013年 / 30卷 / 09期
关键词
metabolism; mass spectrometry; selective androgen receptor modulator; ultra-performance liquid chromatography; validation; DOPING CONTROL PURPOSES; MASS-SPECTROMETRIC CHARACTERIZATION; URINARY METABOLITES; SARMS;
D O I
10.1080/19440049.2013.810346
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
For future targeted screening in National Residue Control Programmes, the metabolism of seven SARMs, from the arylpropionamide and the quinolinone classes, was studied in vitro using S9 bovine liver enzymes. Metabolites were detected and identified with ultra-performance liquid chromatography (UPLC) coupled to time-of-flight mass spectrometry (ToF-MS) and triple quadrupole mass spectrometry (QqQ-MS). Several metabolites were identified and results were compared with literature data on metabolism using a human cell line. Monohydroxylation, nitro-reduction, dephenylation and demethylation were the main S9 in vitro metabolic routes established. Next, an in vivo study was performed by oral administration of the arylpropionamide ostarine to a male calf and urine samples were analysed with UPLC-QToF-MS. Apart from two metabolites resulting from hydroxylation and dephenylation that were also observed in the in vitro study, the bovine in vivo metabolites of ostarine resulted in glucuronidation, sulfation and carboxylation, combined with either a hydroxylation or a dephenylation step. As the intact mother compounds of all SARMs tested are the main compounds present after in vitro incubations, and ostarine is still clearly present in the urine after the in vivo metabolism study in veal calves, the intact mother molecules were selected as the indicator to reveal treatment. The analytical UPLC-QqQ-MS/MS procedure was validated for three commercially available arylpropionamides according to European Union criteria (Commission Decision 2002/657/EC), and resulted in decision limits ranging from 0.025 to 0.05 mu gl(-1) and a detection capability of 0.025 mu gl(-1) in all cases. Adequate precision and intra-laboratory reproducibility (relative standard deviation below 20%) were obtained for all SARMs and the linearity was 0.999 for all compounds. This newly developed method is sensitive and robust, and therefore useful for confirmation and quantification of SARMs in bovine urine samples for residue control programmes and research purposes.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 13 条
[1]  
[Anonymous], 2007, CRLS VIEW STATE ART
[2]   SERMs and SARMs: Detection of their activities with yeast based bioassays [J].
Bovee, Toine F. H. ;
Thevis, Mario ;
Hamers, Astrid R. M. ;
Peijnenburg, Ad A. C. M. ;
Nielen, Michel W. F. ;
Schoonen, Willem G. E. J. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (1-2) :85-92
[3]   Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs) [J].
Gao, Wenqing ;
Dalton, James T. .
DRUG DISCOVERY TODAY, 2007, 12 (5-6) :241-248
[4]   SARM-S4 and metabolites detection in sports drug testing: A case report [J].
Grata, Elia ;
Perrenoud, Laurent ;
Saugy, Martial ;
Baume, Norbert .
FORENSIC SCIENCE INTERNATIONAL, 2011, 213 (1-3) :104-108
[5]   Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes [J].
Kuuranne, Tiia ;
Leinonen, Antti ;
Schaenzer, Wilhelm ;
Kamber, Matthias ;
Kostiainen, Risto ;
Thevis, Mario .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (03) :571-581
[6]   Evidence of the indirect hormonal activity of prohormones using liver S9 metabolic bioactivation and an androgen bioassay [J].
Rijk, J. C. W. ;
Bovee, T. F. H. ;
Groot, M. J. ;
Peijnenburg, A. A. C. M. ;
Nielen, M. W. F. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (03) :417-425
[7]   Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery [J].
Segal, S ;
Narayanan, R ;
Dalton, JT .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) :377-387
[8]   Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes [J].
Thevis, M ;
Kamber, M ;
Schänzer, W .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (05) :870-876
[9]   Mass spectrometry of selective androgen receptor modulators [J].
Thevis, Mario ;
Schaenzer, Wilhelm .
JOURNAL OF MASS SPECTROMETRY, 2008, 43 (07) :865-876
[10]   Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis [J].
Thevis, Mario ;
Kohler, Maxie ;
Maurer, Joachim ;
Schlörer, Nils ;
Kamber, Matthias ;
Schänzer, Wilhelm .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2007, 21 (21) :3477-3486